Clinical and Immunological Factors in Emphysema Progression. Five-Year Prospective Longitudinal Exacerbation Study of Chronic Obstructive Pulmonary Disease (LES-COPD)
about
Obstructive and Restrictive Lung Function Measures and CKD: National Health and Nutrition Examination Survey (NHANES) 2007-2012A Review of Pulmonary Toxicity of Electronic Cigarettes in the Context of Smoking: A Focus on Inflammation.Emphysema Distribution and Diffusion Capacity Predict Emphysema Progression in Human Immunodeficiency Virus Infection.Comparison between Variable and Conventional Volume-Controlled Ventilation on Cardiorespiratory Parameters in Experimental EmphysemaIdentification of subtypes in subjects with mild-to-moderate airflow limitation and its clinical and socioeconomic implications.Alpha-1 Antitrypsin Deficiency: Beyond the Protease/Antiprotease Paradigm.IL-17 in the lung: The Good, the Bad, and the Ugly.Morphological and quantitative evaluation of emphysema in chronic obstructive pulmonary disease patients: A comparative study of MRI with CT.Cigarette Smoke and DNA Cleavage Promote Lung Inflammation and Emphysema.Clinical characteristics of chronic bronchitic, emphysematous and ACOS phenotypes in COPD patients with frequent exacerbations.The cellular and molecular determinants of emphysematous destruction in COPD.Th17/Treg immunoregulation and implications in treatment of sulfur mustard gas-induced lung diseases.Excess Ventilation in Chronic Obstructive Pulmonary Disease-Heart Failure Overlap. Implications for Dyspnea and Exercise Intolerance.Elastin receptor (S-gal) occupancy by elastin peptides modulates T-cell response during murine emphysema.Matrix remodeling in chronic lung diseases.
P2860
Q28387680-4FC59750-A8AA-4D90-AED2-A7D86BD9C56EQ34558199-C8904609-D83F-4BEE-BD50-56CA870055D8Q36208201-7BA97A7E-17B9-4981-A8F6-1F1D12E5D254Q37054524-CF094424-D7C7-4F88-BE72-3A7CDCCB38D6Q38819994-D2488135-69A6-4F52-B0AA-448C0F0A065CQ38937849-1676BED2-7D1A-4059-9606-D314700BFCF1Q40062327-956ABD8A-1BD2-4783-9B39-AD4455C726A9Q40751735-F9E1208A-F8C5-4896-8EB8-6EF985B003F0Q41112254-7416EDD1-1F45-44FC-8F25-9D4F6C693675Q41144316-5B56095C-F750-4E7C-9058-FC685CB3748BQ41534455-642493E4-61D8-4D32-A788-235B3995CCC9Q47585318-3E646981-1ED6-4AFB-BC97-B928EEACD8A5Q47847335-7DB21588-6875-4B6A-80FB-D8B444FE906AQ50964282-A9472B92-F2C0-4CB2-B299-B84EA8D8AAC6Q52646214-2D69640B-D350-4AE3-A9CB-7F2975AA7EC6
P2860
Clinical and Immunological Factors in Emphysema Progression. Five-Year Prospective Longitudinal Exacerbation Study of Chronic Obstructive Pulmonary Disease (LES-COPD)
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Clinical and Immunological Fac ...... e Pulmonary Disease (LES-COPD)
@ast
Clinical and Immunological Fac ...... e Pulmonary Disease (LES-COPD)
@en
type
label
Clinical and Immunological Fac ...... e Pulmonary Disease (LES-COPD)
@ast
Clinical and Immunological Fac ...... e Pulmonary Disease (LES-COPD)
@en
prefLabel
Clinical and Immunological Fac ...... e Pulmonary Disease (LES-COPD)
@ast
Clinical and Immunological Fac ...... e Pulmonary Disease (LES-COPD)
@en
P2093
P2860
P1476
Clinical and Immunological Fac ...... e Pulmonary Disease (LES-COPD)
@en
P2093
David B Corry
Harvey Coxson
Lavannya Pandit
Sarah Perusich
Sean Hesselbacher
Sivasubramanium Bhavani
P2860
P304
P356
10.1164/RCCM.201504-0736OC
P407
P577
2015-08-04T00:00:00Z